The Initial Clinical Application of Arterial Spin Labeling Perfusion MRI in Prostate Cancer

Wenchao Cai,Feiyu Li,Jing Wang,Jue Zhang,Xiaoying Wang,Xuexiang Jiang
2011-01-01
Abstract:Introduction Pulsed arterial spin labeling (PASL) MRI is a non-invasive imaging tool capable of quantitatively measuring the microvascular perfusion characteristics of tissue through tagging arterial water to obtain the blood flow(BF) map[1,2]. The PASL method has been proved to be effective and repeatable in many studies about cerebral diseases[2-4].But the inversion time is an important influence factor for the absolutely quantitative interpretation[5,6].Prostate cancer is a hypervascular tumor certificated by dynamic contrast-enhanced (DCE) MRI and histopathologic findings[7,8]. Therefore, in this study we applied the PASL technique to detect the prostate cancer and to compare the differences blood flow values between the malignant and normal prostate peripheral zones. Methods The local ethics committee approved the study and six patients (mean 78±3years; range 74-82 years) with pathologically confirmed prostate cancer were recruited. All patients had elevated serum prostate-specific antigen (PSA) level (mean 117.9±106.8ng/mL, range 11.41-294.8ng/mL). The PASL pulse sequence was performed on a clinical 3.0T MR scanner (Signa HD; GE Healthcare, Milwaukee, Wisconsin). The PASL protocol was performed with single shot fast spin echo (SSFSE) sequence (TI 1000/1200/1400/1600msec; TR 3500ms; TRM0 6000ms; phases 8). The regions of interest (ROIs) were placed in the cancerous and noncancerous prostate peripheral zone, and the average BF in these regions for each patient was computed respectively.
What problem does this paper attempt to address?